Strategic Partnerships Iktos has established partnerships with prominent industry players such as Merck Ventures, Debiopharm Innovation, and Elsevier, indicating potential sales opportunities through collaboration with these companies or leveraging their networks.

Acquisitions Strategy With the recent acquisition of Synsight, Iktos has expanded its capabilities in AI and drug discovery, presenting sales opportunities for cross-selling products or services to the acquired company's client base.

Diversified Product Portfolio Through partnerships with Bayer for sustainable crop protection products and collaborations in new drug discovery with Nerviano Medical Sciences S.r.l., Iktos offers a diverse range of solutions that could open up avenues for sales across various sectors.

Noteworthy Hires The appointment of Avirup Bose as Chief Business Officer brings valuable expertise to Iktos, potentially leading to strategic sales initiatives, business development opportunities, and broader market reach under his leadership.

Industry Recognition Iktos' recognition with awards like 'AI for Good' and collaborations in prestigious events like the Big Data & AI Paris Congress elevate its credibility, enabling sales teams to leverage these accolades to build trust and secure new business opportunities.